Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775 is registered in ClinicalTrials.gov with Miltenyi Biomedicine GmbH as lead sponsor.

NCT NCT06508775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06508775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Lead sponsor
Miltenyi Biomedicine GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
May 5, 2024
Completion date
December 31, 2040
Enrollment
40 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphatic leukemia, b-cell non hodgkin lymphoma, childhood non-hodgkin lymphoma, chronic lymphatic leukemia, melanoma stage iii, melanoma stage iv, pediatric all